Literature DB >> 15975513

Synthetic alpha-mannosyl ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant Valpha19-Jalpha26 TCR alpha chain.

Naoki Okamoto1, Osamu Kanie, Yi-Ying Huang, Rei Fujii, Hiroko Watanabe, Michio Shimamura.   

Abstract

A NKT cell repertoire is characterized by the expression of the Valpha19-Jalpha26 invariant TCR alpha chain (Valpha19 NKT cell). This repertoire, as well as a well-established Valpha14-Jalpha281 invariant TCR alpha(+) NKT cell subset (Valpha14 NKT cell), has been suggested to have important roles in the regulation of the immune system and, thus, is a major therapeutic target. Here, we attempted to find specific antigens for Valpha19 NKT cells. Valpha19 as well as Valpha14 NKT cells exhibited reactivity to alpha-galactosyl ceramide (alpha-GalCer). Thus, a series of monoglycosyl ceramides with an axially oriented glycosidic linkage between the sugar and ceramide moiety were synthesized and their antigenicity to Valpha19 NKT cells was determined by measuring their immune responses in culture with glycolipids. Comprehensive examinations revealed substantial antigenic activity for Valpha19 NKT cells by alpha-mannosyl ceramide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15975513     DOI: 10.1016/j.chembiol.2005.04.014

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  16 in total

1.  Chemo-enzymatic synthesis of the carbohydrate antigen N-glycolylneuraminic acid from glucose.

Authors:  Oliver M T Pearce; Ajit Varki
Journal:  Carbohydr Res       Date:  2010-04-09       Impact factor: 2.104

2.  Divergent synthetic approach to 6''-modified α-GalCer analogues.

Authors:  Nora Pauwels; Sandrine Aspeslagh; Gerd Vanhoenacker; Koen Sandra; Esther D Yu; Dirk M Zajonc; Dirk Elewaut; Bruno Linclau; Serge Van Calenbergh
Journal:  Org Biomol Chem       Date:  2011-11-01       Impact factor: 3.876

3.  Fighting infection with your MAITs.

Authors:  Dale I Godfrey; Jamie Rossjohn; James McCluskey
Journal:  Nat Immunol       Date:  2010-08       Impact factor: 25.606

Review 4.  Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity.

Authors:  Amelia R Hofstetter; Lucy C Sullivan; Aron E Lukacher; Andrew G Brooks
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

5.  Exceptionally high conservation of the MHC class I-related gene, MR1, among mammals.

Authors:  Kentaro Tsukamoto; Janine E Deakin; Jennifer A Marshall Graves; Keiichiro Hashimoto
Journal:  Immunogenetics       Date:  2012-11-16       Impact factor: 2.846

6.  Impact of sugar stereochemistry on natural killer T cell stimulation by bacterial glycolipids.

Authors:  Shenglou Deng; Jochen Mattner; Zhuo Zang; Li Bai; Luc Teyton; Albert Bendelac; Paul B Savage
Journal:  Org Biomol Chem       Date:  2011-09-16       Impact factor: 3.876

7.  Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.

Authors:  Isaac G Sakala; Lars Kjer-Nielsen; Christopher S Eickhoff; Xiaoli Wang; Azra Blazevic; Ligong Liu; David P Fairlie; Jamie Rossjohn; James McCluskey; Daved H Fremont; Ted H Hansen; Daniel F Hoft
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

8.  Conservation of mucosal associated invariant T (MAIT) cells and the MR1 restriction element in ruminants, and abundance of MAIT cells in spleen.

Authors:  Nick Goldfinch; Peter Reinink; Timothy Connelley; Ad Koets; Ivan Morrison; Ildiko Van Rhijn
Journal:  Vet Res       Date:  2010-05-31       Impact factor: 3.683

9.  Synthesis and biological activity of alpha-L-fucosyl ceramides, analogues of the potent agonist, alpha-D-galactosyl ceramide KRN7000.

Authors:  Natacha Veerapen; Faye Reddington; Gabriel Bricard; Steven A Porcelli; Gurdyal S Besra
Journal:  Bioorg Med Chem Lett       Date:  2010-04-22       Impact factor: 2.823

Review 10.  Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases.

Authors:  Chie Sugimoto; Hiroyoshi Fujita; Hiroshi Wakao
Journal:  World J Stem Cells       Date:  2016-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.